The nanomedicine market was projected at around USD 50 billion in 2011. It is predicted to rise over the forecast phase, at a 14 percent CAGR. 2011 to 2016 is the forecast phase. The market is projected to generate revenue worth about USD 97 billion by the end of the forecast phase. Nanomedicine is already a well acknowledged field and has numerous applications.
The adoption of new applications and technologies in the nanomedicine market would propel its further development. Furthermore, there are various projects and proposals undertaken by different governmental bodies and individually financed organizations. These endorse the profitability of new nanomedicine products and are estimated to increase the market.